Continue Reading... Medical marijuana market expected to grow at 22% CAGR through 2027
Posted in CBD Stocks

Medical marijuana market expected to grow at 22% CAGR through 2027

Medical marijuana is used to relieve clinical symptoms such as pain and epilepsy, and CBD, or cannabidiol, the non-psychoactive ingredient…

Continue Reading... Want $10,000 in Passive Income? Invest $2,000 in Each of These Dividend Stocks
Posted in CBD Stocks

Want $10,000 in Passive Income? Invest $2,000 in Each of These Dividend Stocks

The inflationary environment over the past few years has constricted consumer buying power, resulting in supplementary income requirements by many….

Continue Reading... Emporium Melbourne supports the next generation of Australian designers
Posted in CBD Stocks

Emporium Melbourne supports the next generation of Australian designers

Emporium Melbourne is reaffirming its position as Melbourne CBD’s premium retail destination and a proud supporter of …

Continue Reading... FDA clears Lexaria’s hypertension trial for DehydraTECH-CBD
Posted in CBD Stocks

FDA clears Lexaria’s hypertension trial for DehydraTECH-CBD

The approval, effective as of February 28, 2024, allows the company to begin its U.S. clinical trial, named HYPER-H23-1, aimed…

Continue Reading... Cronos Group (CRON) Q4 2023 Earnings Call Transcript
Posted in CBD Stocks

Cronos Group (CRON) Q4 2023 Earnings Call Transcript

We exited our U.S. CBD operations to focus on adult-use products and we entered … including a half gram trial…

Continue Reading... Using Marijuana to Ease Stress? Focus on CBD, not THC
Posted in CBD Stocks

Using Marijuana to Ease Stress? Focus on CBD, not THC

Folks hoping to quell their anxiety would do best to use cannabis products that don’t get them high, a new…

Continue Reading... Stock Day Media: StrainsForPains, Inc. Discusses Inspiration, App Technology and CBD Market Entrance with The Stock Day Podcast
Posted in CBD Stocks

Stock Day Media: StrainsForPains, Inc. Discusses Inspiration, App Technology and CBD Market Entrance with The Stock Day Podcast

CEO of the Company, Simon Shainberg, joined Stock Day host Matthew Dunehoo … data that helped me design my system,”…

Continue Reading... StrainsForPains, Inc. Discusses Inspiration, App Technology and CBD Market Entrance with The Stock Day Podcast
Posted in CBD Stocks

StrainsForPains, Inc. Discusses Inspiration, App Technology and CBD Market Entrance with The Stock Day Podcast

CEO of the Company, Simon Shainberg, joined Stock Day host Matthew Dunehoo … data that helped me design my system,”…

Continue Reading... SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing
Posted in CBD Stocks

SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing

The Company’s proprietary SCI- 210 treatment combines cannabidiol-rich oil (“CBD”) and CannAmide™, SciSparc’s proprietary … Investor Contact: SciSparc NewsMORE Related…

Continue Reading... Why 180 Life Sciences Corp’s (ATNF) Stock Is Up 1505.13%
Posted in CBD Stocks

Why 180 Life Sciences Corp’s (ATNF) Stock Is Up 1505.13%

Life Sciences Corp’s ATNF share price has surged by 1505.13%, which has investors questioning if this is right time to…